Trellus Health PLC

LSE:TRLS (UK)   Ordinary Shares
£ 0.01 (0%) Dec 24
At Loss
P/B:
0.08
Market Cap:
£ 929.00K ($ 1.19M)
Enterprise V:
£ -5.49M ($ -7.01M)
Volume:
843.53K
Avg Vol (2M):
904.89K
Trade In:
Volume:
843.53K
At Loss
Avg Vol (2M):
904.89K

Business Description

Trellus Health PLC

ISIN : GB00BNNFM402

Share Class Description:

LSE:TRLS: Ordinary Shares
Description
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.96
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.96
Distress
Grey
Safe
Beneish M-Score -3.38
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate 68.1

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 11.6
9-Day RSI 20.22
14-Day RSI 25.1
6-1 Month Momentum % -53.45
12-1 Month Momentum % -79.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.15
Quick Ratio 14.15
Cash Ratio 13.81
Days Sales Outstanding 1227.98

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -13020.93
Net Margin % -12204.65
FCF Margin % -14253.49
ROE % -34.68
ROA % -33.61
ROIC % -92.39
ROC (Joel Greenblatt) % -20484.15
ROCE % -37

Financials (Next Earnings Date:2025-04-23 Est.)

LSE:TRLS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Trellus Health PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 0.043
EPS (TTM) (£) -0.032
Beta 0.32
Volatility % 84.62
14-Day RSI 25.1
14-Day ATR (£) 0.000401
20-Day SMA (£) 0.0062
12-1 Month Momentum % -79.23
52-Week Range (£) 0.0055 - 0.07375
Shares Outstanding (Mil) 161.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Trellus Health PLC Filings

Filing Date Document Date Form
No Filing Data

Trellus Health PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

Trellus Health PLC Frequently Asked Questions

What is Trellus Health PLC(LSE:TRLS)'s stock price today?
The current price of LSE:TRLS is £0.01. The 52 week high of LSE:TRLS is £0.07 and 52 week low is £0.01.
When is next earnings date of Trellus Health PLC(LSE:TRLS)?
The next earnings date of Trellus Health PLC(LSE:TRLS) is 2025-04-23 Est..
Does Trellus Health PLC(LSE:TRLS) pay dividends? If so, how much?
Trellus Health PLC(LSE:TRLS) does not pay dividend.

Press Release

Subject Date
No Press Release